Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature

J Chemother. 2010 Apr;22(2):134-6. doi: 10.1179/joc.2010.22.2.134.

Abstract

Testicular germ-cell tumors are the most common solid tumor in young men, with an incidence peak between the ages of 20 and 35 years. Even if rare, arterial thromboembolism is a serious and possible complication during cisplatin-based chemotherapy in young patients. The strong association between rapid treatment and favorable outcome is well known. Oncologists need to recognize the symptoms and to alert a stroke unit as soon as possible. We report the management of a young patient affected by non seminomatous testicular neoplasm without cardiovascular risk factors who developed an ischemic stroke during cisplatin-based treatment. We also review the relevant literature.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Ischemia / chemically induced*
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal / drug therapy*
  • Stroke / chemically induced*
  • Testicular Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Cisplatin